Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta‐analysis

AIMS/INTRODUCTION: The optimal therapy for latent autoimmune diabetes in adults (LADA) remains undefined. Increasing evidence has shown that sitagliptin and insulin treatment can benefit patients with LADA, but the efficacy still lacks systematic evaluation. We carried out this systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tong, Cai, Yinhe, Tang, Liting, Lian, Youwei, Liu, Min, Liu, Chaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434588/
https://www.ncbi.nlm.nih.gov/pubmed/35445591
http://dx.doi.org/10.1111/jdi.13814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434588/
https://www.ncbi.nlm.nih.gov/pubmed/35445591
http://dx.doi.org/10.1111/jdi.13814

Ejemplares similares